Kymera Therapeutics Inc (KYMR)
47.55
+2.57
(+5.71%)
USD |
NASDAQ |
Nov 25, 15:54
Kymera Therapeutics Shareholders Equity (Quarterly): 892.93M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 892.93M |
| June 30, 2024 | 684.92M |
| March 31, 2024 | 711.20M |
| December 31, 2023 | 394.97M |
| September 30, 2023 | 395.54M |
| June 30, 2023 | 435.43M |
| March 31, 2023 | 462.00M |
| December 31, 2022 | 490.15M |
| September 30, 2022 | 512.88M |
| June 30, 2022 | 397.95M |
| Date | Value |
|---|---|
| March 31, 2022 | 428.72M |
| December 31, 2021 | 459.64M |
| September 30, 2021 | 483.14M |
| June 30, 2021 | 258.10M |
| March 31, 2021 | 275.25M |
| December 31, 2020 | 283.89M |
| September 30, 2020 | 294.68M |
| June 30, 2020 | 104.04M |
| December 31, 2019 | -74.41M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-74.41M
Minimum
Dec 2019
892.93M
Maximum
Sep 2024
415.32M
Average
428.72M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| Amgen Inc | 7.527B |
| Voyager Therapeutics Inc | 330.31M |
| Denali Therapeutics Inc | 1.318B |
| Vir Biotechnology Inc | 1.241B |
| CEL-SCI Corp | 8.473M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.035B |
| Total Liabilities (Quarterly) | 141.91M |
| Current Ratio | 8.548 |